{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T07:24:08Z","timestamp":1794468248455,"version":"4.9.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T00:00:00Z","timestamp":1643414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T00:00:00Z","timestamp":1643414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["F31 MH124425"],"award-info":[{"award-number":["F31 MH124425"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["F31 DA045428"],"award-info":[{"award-number":["F31 DA045428"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R21 DA0488554"],"award-info":[{"award-number":["R21 DA0488554"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["U01 DA051947"],"award-info":[{"award-number":["U01 DA051947"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DP1 DA042078"],"award-info":[{"award-number":["DP1 DA042078"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["F99 NS108543"],"award-info":[{"award-number":["F99 NS108543"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol."],"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Persistent transcriptional events in ventral tegmental area (VTA) and other reward relevant brain regions contribute to enduring behavioral adaptations that characterize substance use disorder. Recent data from our laboratory indicate that aberrant accumulation of the newly discovered histone post-translational modification (PTM), H3 dopaminylation at glutamine 5 (H3Q5dop), contributes significantly to cocaine-seeking behavior following prolonged periods of abstinence. It remained unclear, however, whether this modification is important for relapse vulnerability in the context of other drugs of abuse, such as opioids. Here, we showed that H3Q5dop plays a critical role in heroin-mediated transcriptional plasticity in midbrain regions, particularly the VTA. In rats undergoing abstinence from heroin self-administration (SA), we found acute and persistent accumulation of H3Q5dop in VTA. Attenuation of H3Q5dop during abstinence induced persistent changes in gene expression programs associated with neuronal signaling and dopaminergic function in heroin abstinence and led to reduced heroin-seeking behavior. Interestingly, the observed changes in molecular pathways after heroin SA showed significant yet reversed overlap with the same genes altered in cocaine SA. These findings establish an essential role for H3Q5dop, and its downstream transcriptional consequences, in heroin-induced functional plasticity in VTA.<\/jats:p>","DOI":"10.1038\/s41386-022-01279-4","type":"journal-article","created":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T04:02:58Z","timestamp":1643428978000},"page":"1776-1783","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Histone H3 dopaminylation in ventral tegmental area underlies heroin-induced transcriptional and behavioral plasticity in male rats"],"prefix":"10.1038","volume":"47","author":[{"given":"Sasha L.","family":"Fulton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swarup","family":"Mitra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley E.","family":"Lepack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer A.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8174-3927","authenticated-orcid":false,"given":"Andrew F.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Converse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mason","family":"Hochstetler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6927-9236","authenticated-orcid":false,"given":"David M.","family":"Dietz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Maze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,29]]},"reference":[{"key":"1279_CR1","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1124\/jpet.103.052407","volume":"306","author":"V Raghavendra","year":"2003","unstructured":"Raghavendra V, Tanga F, DeLeo JA. Inhibition of microglial activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy. J Pharmacol Exp Therapeutics. 2003;306:624\u201330.","journal-title":"J Pharmacol Exp Therapeutics"},{"key":"1279_CR2","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1001\/jama.2013.278861","volume":"310","author":"BM Kuehn","year":"2013","unstructured":"Kuehn BM. Samhsa: pain medication abuse a common path to heroin: experts say this pattern likely driving heroin resurgence. JAMA. 2013;310:1433\u20134.","journal-title":"JAMA."},{"key":"1279_CR3","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1056\/NEJMsa1406143","volume":"372","author":"RC Dart","year":"2015","unstructured":"Dart RC, Surratt HL, Cicero TJ, Parrino MW, Severtson SG, Bucher-Bartelson B, et al. Trends in Opioid Analgesic Abuse and Mortality in the United States. N Eng J Med. 2015;372:241\u20138.","journal-title":"N Eng J Med."},{"key":"1279_CR4","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.annepidem.2018.05.008","volume":"28","author":"LC Palombi","year":"2018","unstructured":"Palombi LC, St Hill CA, Lipsky MS, Swanoski MT, Lutfiyya MN. A scoping review of opioid misuse in the rural United States. Annals of epidemiology. 2018;28:641\u201352.","journal-title":"Annals of epidemiology"},{"key":"1279_CR5","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1001\/jamapsychiatry.2017.0163","volume":"74","author":"BK Madras","year":"2017","unstructured":"Madras BK. The surge of opioid use, addiction, and overdoses: responsibility and response of the US health care system. JAMA Psychiatry. 2017;74:441\u20132.","journal-title":"JAMA Psychiatry"},{"key":"1279_CR6","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/35094560","volume":"2","author":"SE Hyman","year":"2001","unstructured":"Hyman SE, Malenka RC. Addiction and the brain: the neurobiology of compulsion and its persistence. Nat Rev Neurosci. 2001;2:695\u2013703.","journal-title":"Nat Rev Neurosci"},{"key":"1279_CR7","doi-asserted-by":"publisher","first-page":"8324","DOI":"10.1523\/JNEUROSCI.21-21-08324.2001","volume":"21","author":"EJ Nestler","year":"2001","unstructured":"Nestler EJ. Psychogenomics: opportunities for understanding addiction. J Neurosci. 2001;21:8324\u20137.","journal-title":"J Neurosci"},{"key":"1279_CR8","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nrn2515","volume":"10","author":"PW Kalivas","year":"2009","unstructured":"Kalivas PW. The glutamate homeostasis hypothesis of addiction. Nat Rev Neurosci. 2009;10:561\u201372.","journal-title":"Nat Rev Neurosci"},{"key":"1279_CR9","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.tins.2010.06.003","volume":"33","author":"ME Wolf","year":"2010","unstructured":"Wolf ME. The Bermuda triangle of cocaine-induced neuroadaptations. Trends Neurosci. 2010;33:391\u20138.","journal-title":"Trends Neurosci"},{"issue":"Feb","key":"1279_CR10","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.biopsych.2020.08.005","volume":"89","author":"CT Werner","year":"2021","unstructured":"Werner CT, Altshuler RD, Shaham Y, Li X. Epigenetic Mechanisms in Drug Relapse. Biol Psychiatry. 2021;89:331\u20138.","journal-title":"Biol Psychiatry"},{"key":"1279_CR11","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1126\/science.aaw8806","volume":"368","author":"AE Lepack","year":"2020","unstructured":"Lepack AE, Werner CT, Stewart AF, Fulton SL, Zhong P, Farrelly LA, et al. Dopaminylation of histone H3 in ventral tegmental area regulates cocaine seeking. Science. 2020;368:197\u2013201.","journal-title":"Science."},{"key":"1279_CR12","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/s41586-019-1024-7","volume":"567","author":"LA Farrelly","year":"2019","unstructured":"Farrelly LA, Thompson RE, Zhao S, Lepack AE, Lyu Y, Bhanu NV, et al. Histone serotonylation is a permissive modification that enhances TFIID binding to H3K4me3. Nature. 2019;567:535\u20139.","journal-title":"Nature."},{"key":"1279_CR13","doi-asserted-by":"crossref","unstructured":"Zhao S, Chuh KN, Zhang B, Dul BE, Thompson RE, Farrelly LA, et al. Histone H3Q5 serotonylation stabilizes H3K4 methylation and potentiates its readout. Proceedings of the National Academy of Sciences. 2021;118.","DOI":"10.1073\/pnas.2016742118"},{"key":"1279_CR14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/(SICI)1098-2396(199910)34:1<11::AID-SYN2>3.0.CO;2-5","volume":"34","author":"MR Gerasimov","year":"1999","unstructured":"Gerasimov MR, Ashby CR Jr, Gardner EL, Mills MJ, Brodie JD, Dewey SL. Gamma\u2013vinyl GABA inhibits methamphetamine, heroin, or ethanol\u2013induced increases in nucleus accumbens dopamine. Synapse. 1999;34:11\u20139.","journal-title":"Synapse."},{"key":"1279_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-018-07882-8","volume":"10","author":"JA Martin","year":"2019","unstructured":"Martin JA, Werner CT, Mitra S, Zhong P, Wang Z-J, Gobira PH, et al. A novel role for the actin-binding protein drebrin in regulating opiate addiction. Nat Commun. 2019;10:1\u201311.","journal-title":"Nat Commun"},{"key":"1279_CR16","doi-asserted-by":"crossref","unstructured":"Mitra S, Gobira PH, Werner CT, Martin JA, Iida M, Thomas SA, et al. A role for the endocannabinoid enzymes monoacylglycerol and diacylglycerol lipases in cue\u2013induced cocaine craving following prolonged abstinence. Addict Biol. 2021:e13007.","DOI":"10.1111\/adb.13007"},{"key":"1279_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00213-002-1224-x","volume":"168","author":"Y Shaham","year":"2003","unstructured":"Shaham Y, Shalev U, Lu L, De Wit H, Stewart J. The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmacol. 2003;168:3\u201320.","journal-title":"Psychopharmacol."},{"key":"1279_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/pr.54.1.1","volume":"54","author":"U Shalev","year":"2002","unstructured":"Shalev U, Grimm JW, Shaham Y. Neurobiology of relapse to heroin and cocaine seeking: a review. Pharmacol Rev. 2002;54:1\u201342.","journal-title":"Pharmacol Rev"},{"key":"1279_CR19","doi-asserted-by":"crossref","unstructured":"Lepack AE, Bagot RC, Pe\u00f1a CJ, Loh Y-HE, Farrelly LA, Lu Y, et al. Aberrant H3. 3 dynamics in NAc promote vulnerability to depressive-like behavior. Proc Natl Acad Sci. 2016;113:12562-7.","DOI":"10.1073\/pnas.1608270113"},{"key":"1279_CR20","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/ng.3552","volume":"48","author":"A Okbay","year":"2016","unstructured":"Okbay A, Baselmans BM, De Neve J-E, Turley P, Nivard MG, Fontana MA, et al. Genetic variants associated with subjective well-being, depressive symptoms, and neuroticism identified through genome-wide analyses. Nat Genet. 2016;48:624\u201333.","journal-title":"Nat Genet"},{"key":"1279_CR21","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/s41593-020-0624-8","volume":"23","author":"N Habib","year":"2020","unstructured":"Habib N, McCabe C, Medina S, Varshavsky M, Kitsberg D, Dvir-Szternfeld R, et al. Disease-associated astrocytes in Alzheimer\u2019s disease and aging. Nat Neurosci. 2020;23:701\u20136.","journal-title":"Nat Neurosci"},{"key":"1279_CR22","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1111\/jnc.12074","volume":"124","author":"S Fanous","year":"2013","unstructured":"Fanous S, Guez\u2013Barber DH, Goldart EM, Schrama R, Theberge FR, Shaham Y, et al. Unique gene alterations are induced in FACS\u2013purified Fos\u2013positive neurons activated during cue\u2013induced relapse to heroin seeking. J Neurochem. 2013;124:100\u20138.","journal-title":"J Neurochem"},{"key":"1279_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:1\u201321.","journal-title":"Genome Biol"},{"key":"1279_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-27903-2","volume":"8","author":"KM Cahill","year":"2018","unstructured":"Cahill KM, Huo Z, Tseng GC, Logan RW, Seney ML. Improved identification of concordant and discordant gene expression signatures using an updated rank-rank hypergeometric overlap approach. Sci Rep. 2018;8:1\u201311.","journal-title":"Sci Rep"},{"key":"1279_CR25","unstructured":"Shen L, Sinai M GeneOverlap: Test and visualize gene overlaps. R package version 1.20. 0. 2019."},{"key":"1279_CR26","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1093\/bioinformatics\/btw623","volume":"33","author":"M Alhamdoosh","year":"2017","unstructured":"Alhamdoosh M, Ng M, Wilson NJ, Sheridan JM, Huynh H, Wilson MJ, et al. Combining multiple tools outperforms individual methods in gene set enrichment analyses. Bioinformatics. 2017;33:414\u201324.","journal-title":"Bioinformatics."},{"key":"1279_CR27","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.tins.2011.06.001","volume":"34","author":"CL Pickens","year":"2011","unstructured":"Pickens CL, Airavaara M, Theberge F, Fanous S, Hope BT, Shaham Y. Neurobiology of the incubation of drug craving. Trends Neurosci. 2011;34:411\u201320.","journal-title":"Trends Neurosci"},{"key":"1279_CR28","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1038\/sj.mt.6300227","volume":"15","author":"S Reimsnider","year":"2007","unstructured":"Reimsnider S, Manfredsson FP, Muzyczka N, Mandel RJ. Time course of transgene expression after intrastriatal pseudotyped rAAV2\/1, rAAV2\/2, rAAV2\/5, and rAAV2\/8 transduction in the rat. Mol Ther. 2007;15:1504\u201311.","journal-title":"Mol Ther"},{"key":"1279_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41421-018-0060-z","volume":"4","author":"C Wei","year":"2018","unstructured":"Wei C, Han X, Weng D, Feng Q, Qi X, Li J, et al. Response dynamics of midbrain dopamine neurons and serotonin neurons to heroin, nicotine, cocaine, and MDMA. Cell Discov. 2018;4:1\u201316.","journal-title":"Cell Discov"},{"key":"1279_CR30","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.neuron.2017.12.022","volume":"97","author":"H Yang","year":"2018","unstructured":"Yang H, de Jong JW, Tak Y, Peck J, Bateup HS, Lammel S. Nucleus accumbens subnuclei regulate motivated behavior via direct inhibition and disinhibition of VTA dopamine subpopulations. Neuron. 2018;97:434\u201349. e4","journal-title":"Neuron."},{"key":"1279_CR31","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.neuron.2015.08.019","volume":"87","author":"R Al-Hasani","year":"2015","unstructured":"Al-Hasani R, McCall JG, Shin G, Gomez AM, Schmitz GP, Bernardi JM, et al. Distinct subpopulations of nucleus accumbens dynorphin neurons drive aversion and reward. Neuron. 2015;87:1063\u201377.","journal-title":"Neuron."},{"key":"1279_CR32","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.neuroscience.2007.10.012","volume":"151","author":"J Rogers","year":"2008","unstructured":"Rogers J, Ghee S, See R. The neural circuitry underlying reinstatement of heroin-seeking behavior in an animal model of relapse. Neuroscience. 2008;151:579\u201388.","journal-title":"Neuroscience."},{"key":"1279_CR33","doi-asserted-by":"publisher","first-page":"3321","DOI":"10.1523\/JNEUROSCI.22-09-03321.2002","volume":"22","author":"TJ De Vries","year":"2002","unstructured":"De Vries TJ, Shippenberg TS. Neural systems underlying opiate addiction. J Neurosci. 2002;22:3321\u20135.","journal-title":"J Neurosci"},{"key":"1279_CR34","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1038\/npp.2017.303","volume":"43","author":"JA Martin","year":"2018","unstructured":"Martin JA, Caccamise A, Werner CT, Viswanathan R, Polanco JJ, Stewart AF, et al. A novel role for oligodendrocyte precursor cells (OPCs) and Sox10 in mediating cellular and behavioral responses to heroin. Neuropsychopharmacology. 2018;43:1385\u201394.","journal-title":"Neuropsychopharmacology."},{"key":"1279_CR35","doi-asserted-by":"publisher","first-page":"3619","DOI":"10.1016\/j.celrep.2018.08.080","volume":"24","author":"D Avey","year":"2018","unstructured":"Avey D, Sankararaman S, Yim AK, Barve R, Milbrandt J, Mitra RD. Single-cell RNA-seq uncovers a robust transcriptional response to morphine by glia. Cell reports. 2018;24:3619\u201329. e4.","journal-title":"Cell reports"},{"key":"1279_CR36","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1038\/sj.npp.1301089","volume":"31","author":"DN Albertson","year":"2006","unstructured":"Albertson DN, Schmidt CJ, Kapatos G, Bannon MJ. Distinctive profiles of gene expression in the human nucleus accumbens associated with cocaine and heroin abuse. Neuropsychopharmacology. 2006;31:2304\u201312.","journal-title":"Neuropsychopharmacology."},{"key":"1279_CR37","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/nrn3104","volume":"12","author":"A Badiani","year":"2011","unstructured":"Badiani A, Belin D, Epstein D, Calu D, Shaham Y. Opiate versus psychostimulant addiction: the differences do matter. Nat Rev Neurosci. 2011;12:685\u2013700.","journal-title":"Nat Rev Neurosci"},{"key":"1279_CR38","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1073\/pnas.91.1.385","volume":"91","author":"SA Mackler","year":"1994","unstructured":"Mackler SA, Eberwine JH. Cellular adaptation to opiates alters ion-channel mRNA levels. Proc Natl Acad Sci. 1994;91:385\u20139.","journal-title":"Proc Natl Acad Sci"},{"key":"1279_CR39","doi-asserted-by":"crossref","unstructured":"George BE, Barth SH, Kuiper LB, Holleran KM, Lacy RT, Raab-Graham KF, et al. Enhanced heroin self-administration and distinct dopamine adaptations in female rats. Neuropsychopharmacology. 2021:1-10.","DOI":"10.1038\/s41386-021-01035-0"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41386-022-01279-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41386-022-01279-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41386-022-01279-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T08:44:21Z","timestamp":1700124261000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41386-022-01279-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,29]]},"references-count":39,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["1279"],"URL":"https:\/\/doi.org\/10.1038\/s41386-022-01279-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.03.26.437235","asserted-by":"object"}]},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,29]]},"assertion":[{"value":"10 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}